A 63-year-old man complains of years long progressive enlargement of his nose. He has tried topical metronidazole cream and oral doxycycline without improvement. He is very embarrassed by the condition.
A rare type of skin cancer has been linked to allergic reactions to metal implants.
Nothing makes your practice easier than quickly scrolling through MPR's extensive database of Acne drug treatments.
New findings from the Psoriasis Longitudinal Assessment and Registry (PSOLAR) indicate significantly better persistency and lower rates of discontinuation therapy with Stelara (ustekinumab; Jannsen Biotech) compared with anti-tumor necrosis factor (TNF)-alpha treatments.
Medac Pharma announced the launch of Rasuvo (methotrexate) injection for patients with rheumatoid arthritis, polyarticular course juvenile idiopathic arthritis (pJIA), and psoriasis.
AbbVie announced that the Food and Drug Administration (FDA) has approved the use of Humira (adalimumab) for moderately to severely active polyarticular juvenile idiopathic arthritis (pJIA) to reducing signs and symptoms in patients aged ≥2 years.
Ranbaxy announced the launch of Absorica (isotretinoin) 25mg and 35mg capsules for the treatment of severe recalcitrant nodular acne in patients ≥12 years old.
Men with male pattern baldness may face a higher risk of developing an aggressive type of prostate cancer than men with no balding.